Intellectual Property

VCH Research Institute supports partnerships between our researchers and industry that investigate areas of mutual interest, the commercialization, distribution and dissemination of research outputs.

Vancouver Coastal Health’s extensive acute and community health services offer rich environments for staff to research new ideas, products and services that have the potential to benefit society.   The underlying philosophy of the Intellectual Property policy is to:

  • recognize the contributions of VCH, staff and other parties in the creation of Intellectual Property;
  • ensure that created IP is commercialized by the appropriate party; and
  • ensure that the benefits of any commercialized IP are shared fairly between all relevant parties.

Policy and Related Forms


We support interaction between VCH Research Institute researchers and industry and other community partners in many different forms, including research partnerships that investigate areas of mutual interest, the commercialization, distribution and dissemination of research outputs, and the development of entrepreneurial talent and new ventures.

UBC Researchers / Inventors

Individuals involved in research at VCH Research Institute who have UBC appointments are subject to The University of British Columbia’s Policy #88: Patents and Licensing (“UBC’s IP Policy”) and the terms and conditions of any affiliation agreements between VCH and The University of British Columbia (“UBC”).  Visit University-Industry Liaison Office for more information.

Inventors from other Organizations

In cases where an Inventor subject to the VCH Intellectual Property Policy is also subject to the policy of another organization (e.g. hospital, health authority, or other external institutions), the determination of rights to a VCH Invention and the allocation of Net Revenue, Equity and Net Proceeds arising out of the Commercialization of the VCH Invention shall be subject to the terms and conditions of agreements between VCH and the external institution in force at the time of disclosure of the VCH Invention, or in the absence of such an agreement to negotiation between the institutions involved.  Contact Stephania Manusha, Director, Clinical Trials Administration, for more information.